40 至 64 岁私营保险女性的乳腺癌筛查费用趋势。
Trends in Breast Cancer Screening Costs Among Privately Insured Women Aged 40 to 64 Years.
机构信息
Department of Internal Medicine, Section of General Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale Cancer Center and Yale University School of Medicine, New Haven, Connecticut.
出版信息
JAMA Intern Med. 2021 Dec 1;181(12):1665-1668. doi: 10.1001/jamainternmed.2021.4832.
Abstract
This cohort study characterizes changes in breast cancer screening costs as digital breast tomosynthesis has been adopted at both the patient and population levels.
摘要
本队列研究描述了在患者和人群两个层面采用数字乳腺断层合成技术后，乳腺癌筛查成本的变化情况。
相似文献
1
Trends in Breast Cancer Screening Costs Among Privately Insured Women Aged 40 to 64 Years.40 至 64 岁私营保险女性的乳腺癌筛查费用趋势。
JAMA Intern Med. 2021 Dec 1;181(12):1665-1668. doi: 10.1001/jamainternmed.2021.4832.
2
Use and Costs of Breast Cancer Screening for Women in Their 40s in a US Population With Private Insurance.美国私人保险覆盖人群中 40 多岁女性乳腺癌筛查的应用和费用。
JAMA Intern Med. 2020 May 1;180(5):799-801. doi: 10.1001/jamainternmed.2020.0262.
3
Out-of-Pocket Costs of Diagnostic Breast Imaging Services After Screening Mammography Among Commercially Insured Women From 2010 to 2017.2010 年至 2017 年商业保险女性接受筛查性乳房 X 光检查后的诊断性乳房成像服务自付费用。
JAMA Netw Open. 2021 Aug 2;4(8):e2121347. doi: 10.1001/jamanetworkopen.2021.21347.
4
Breast, Cervical, and Colorectal Cancer Screening: Patterns Among Women With Medicaid and Commercial Insurance.乳腺癌、宫颈癌和结直肠癌筛查：有医疗补助和商业保险的女性中的模式。
Am J Prev Med. 2019 Sep;57(3):394-402. doi: 10.1016/j.amepre.2019.04.010. Epub 2019 Aug 1.
5
Elimination of cost-sharing and receipt of screening for colorectal and breast cancer.取消费用分担以及接受结直肠癌和乳腺癌筛查。
Cancer. 2015 Sep 15;121(18):3272-80. doi: 10.1002/cncr.29494. Epub 2015 Jun 4.
6
Factors Associated with Adherence to Adjuvant Endocrine Therapy Among Privately Insured and Newly Diagnosed Breast Cancer Patients: A Quantile Regression Analysis.与私人保险和新诊断乳腺癌患者内分泌辅助治疗依从性相关的因素：分位数回归分析。
J Manag Care Spec Pharm. 2016 Aug;22(8):969-78. doi: 10.18553/jmcp.2016.22.8.969.
7
Utilization and Cost of Mammography Screening Among Commercially Insured Women 50 to 64 Years of Age in the United States, 2012-2016.美国 2012-2016 年商业保险女性 50-64 岁人群的乳腺 X 线筛查利用情况和成本。
J Womens Health (Larchmt). 2020 Mar;29(3):327-337. doi: 10.1089/jwh.2018.7543. Epub 2019 Oct 15.
8
Insurance and inpatient care: differences in length of stay and costs between surgically treated cancer patients.保险与住院治疗：手术治疗癌症患者的住院时间和费用差异。
Cancer. 2012 Oct 15;118(20):5084-91. doi: 10.1002/cncr.27508. Epub 2012 Mar 13.
9
The impact of sociodemographic factors and health insurance coverage in the diagnosis and clinicopathological characteristics of breast cancer in Brazil: AMAZONA III study (GBECAM 0115).社会人口因素和医疗保险覆盖情况对巴西乳腺癌诊断和临床病理特征的影响：AMAZONA III 研究（GBECAM 0115）。
Breast Cancer Res Treat. 2020 Oct;183(3):749-757. doi: 10.1007/s10549-020-05831-y. Epub 2020 Jul 29.
10
The relation between health insurance coverage and clinical outcomes among women with breast cancer.乳腺癌女性的医疗保险覆盖范围与临床结局之间的关系。
N Engl J Med. 1993 Jul 29;329(5):326-31. doi: 10.1056/NEJM199307293290507.
引用本文的文献
1
Association study between drug prescriptions and Alzheimer's disease claims in a commercial insurance database.药物处方与商业保险数据库中阿尔茨海默病索赔之间的关联性研究。
Alzheimers Res Ther. 2023 Jun 24;15(1):118. doi: 10.1186/s13195-023-01255-0.
2
Health Benefits and Cost-Effectiveness of Children's Oncology Group Breast Cancer Screening Guidelines for Chest-Irradiated Hodgkin Lymphoma Survivors.儿童肿瘤学组胸部放疗霍奇金淋巴瘤幸存者乳腺癌筛查指南的健康获益和成本效益。
J Clin Oncol. 2023 Feb 10;41(5):1046-1058. doi: 10.1200/JCO.22.00574. Epub 2022 Oct 20.
3
Imaging Surveillance Options for Individuals With a Personal History of Breast Cancer: Expert Panel Narrative Review.具有乳腺癌个人病史者的影像学监测选择：专家小组叙事性综述。
AJR Am J Roentgenol. 2022 Dec;219(6):854-868. doi: 10.2214/AJR.22.27635. Epub 2022 May 11.
Zotero 插件